Patient materials need to be clear to non-specialists without weakening safety information. Good language decisions depend on clinical context and on the exact group of people who will read the document.
Why patient-facing Greek needs its own approach
A clinician can resolve an ambiguous phrase from experience; a patient usually cannot. The same instruction may be read at home, under stress, without anyone to ask.
Patient content also travels across channels. The same instruction may appear in a printed leaflet, a patient portal, a text reminder and a discharge letter, and it should say the same thing in each.
For medicines, readability is an established requirement. The European Commission’s guideline on the readability of the labelling and package leaflet ↗ sets out how patient information should be written and tested. Its principles, such as short sentences, clear headings and consistent terms, are useful well beyond package leaflets.
Choose the reader level
An appointment instruction, consent form and clinical report serve different people. Mark terms that must remain technical and explain where plain language is appropriate.
Plain language does not mean simplifying the facts. It means shorter sentences, active verbs and everyday words where they are accurate, with technical terms explained the first time they appear.
Consider who else reads the text. Caregivers, interpreters and pharmacists may rely on the same document, so key terms should stay recognizable to professionals too.
Keep names of procedures and medicines consistent with approved references. For centrally authorized medicines, EMA publishes product-information (QRD) templates ↗ with standard headings and wording in the EU languages, including Greek. See how this fits our wider healthcare and pharmaceutical work.
Protect the essentials
Warnings, negation, dosage, timing and conditions need focused review. A missing “not” or a shifted time reference can reverse an instruction.
Numbers deserve their own check. Units, decimal commas, time formats and frequencies such as “twice a day” must be unambiguous in Greek and match the source exactly.
Tables and checkboxes can change meaning when formatting shifts. When the source is unclear, ask the content owner rather than improvising a medical instruction.
Handle uncertain source text
Source materials may contain unexplained abbreviations or conflicting instructions. The linguist should raise a focused question with the exact location instead of expanding an abbreviation by guesswork.
A documented answer from the content owner can then be applied consistently wherever the issue recurs. Recording these answers in a shared glossary prevents the same question from reappearing in the next update.
The same discipline applies to translated forms. A consent form or questionnaire should keep the structure and response options of the source, so answers can be compared reliably.
Check comprehension and layout
Review the rendered file and, for important patient journeys, consider feedback from the intended audience or a clinical reviewer. Independent revision confirms the translation against the source; clinical review confirms that the instruction works in practice.
Layout matters as much as wording. Multilingual DTP checks keep warnings, tables and icons in place, while accessible formats help patients who use screen readers. Translation quality is one part of a wider content governance process and does not replace clinical validation.
For device instructions, these principles apply alongside the device-specific points in our article on Greek medical device content.
A checklist for patient materials
- Define the intended reader. Record age group, setting and whether a caregiver may read the text.
- Agree the terminology. Align procedure and medicine names with approved references.
- Review high-consequence instructions. Check warnings, negation, dosage, timing and conditions separately.
- Query unclear source text. Ask the content owner and apply the answer consistently.
- Check the final layout. Review tables, checkboxes and icons in the rendered file.
- Complete clinical sign-off. Confirm the content with the responsible clinical reviewer before release.
Translation supports patient safety; responsibility for clinical content stays with the healthcare provider or manufacturer.
Further reading: European Commission: Guideline on the readability of the labelling and package leaflet ↗; EMA: Product-information (QRD) templates ↗.